ReviewFrontiers in physiology2013

Targeting cardiac β-adrenergic signaling via GRK2 inhibition for heart failure therapy.

Alessandro Cannavo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.